Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Rosumore ASP 10 Capsule is a dual-combination cardiovascular medication containing Rosuvastatin, a potent statin for lipid-lowering therapy, and Aspirin, an antiplatelet agent used to prevent blood clot formation. Rosuvastatin works by inhibiting HMG-CoA reductase, thereby lowering LDL cholesterol, total cholesterol, and triglycerides, while increasing HDL cholesterol. Aspirin irreversibly inhibits platelet cyclooxygenase (COX-1), reducing thromboxane A2 synthesis and preventing platelet aggregation. Together, this combination provides a synergistic effect by addressing two major risk factors of atherosclerotic cardiovascular disease: dyslipidemia and thrombosis. Rosumore ASP 10 is commonly prescribed for patients with existing cardiovascular risk factors or as part of secondary prevention following myocardial infarction, stroke, or angioplasty/stent placement. The 10 mg statin dose combined with 75 mg low-dose aspirin offers effective long-term prevention of cardiovascular events with a convenient once-daily dosage.
Common side effects include mild gastrointestinal irritation, heartburn, nausea, abdominal pain, muscle pain, headache, and dizziness. Aspirin may increase the risk of bleeding, gastritis, or gastric ulcers, while Rosuvastatin can occasionally cause muscle-related issues such as myalgia or, rarely, rhabdomyolysis. Rare adverse effects include liver enzyme elevation and hypersensitivity reactions. Patients should be monitored for any signs of unusual bleeding, black/tarry stools, or unexplained muscle pain.
Rosumore ASP 10 Capsule is indicated for the primary and secondary prevention of cardiovascular events in patients with hyperlipidemia, atherosclerosis, coronary artery disease, diabetes with risk factors, or a history of myocardial infarction or ischemic stroke. It is particularly useful for patients requiring both lipid-lowering therapy and antiplatelet protection.
Rosumore ASP 10 Capsule should only be used under the supervision of a healthcare provider. It is contraindicated in patients with active peptic ulcer, bleeding disorders, severe liver or kidney impairment, or hypersensitivity to statins or NSAIDs. It should not be used during pregnancy or breastfeeding. Alcohol consumption should be minimized as it increases the risk of gastrointestinal bleeding and liver injury. Caution is advised in patients taking other anticoagulants or antiplatelet drugs due to an increased bleeding risk. Periodic lipid profile and liver function tests are recommended for safe long-term use.
Store Rosumore ASP 10 Capsule in a cool, dry place below 30°C. Protect it from direct sunlight and moisture. Keep out of reach of children and pets. Do not use the capsule after the expiry date mentioned on the packaging.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 10 mg fenofibrate tablet